Company profile for Lattice Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lattice Biologics Ltd. is an emerging leader in the field of cellular therapies and tissue engineering. Lattice develops and processes biologic allograft products for domestic and international markets. Lattice’s allograft products are used in a variety of clinical applications, including: Enhancing fusion in spine surgery Enhancing breast reconstruction post mastectomy for breast cancer patients Sports medicine indi...
Lattice Biologics Ltd. is an emerging leader in the field of cellular therapies and tissue engineering. Lattice develops and processes biologic allograft products for domestic and international markets. Lattice’s allograft products are used in a variety of clinical applications, including: Enhancing fusion in spine surgery Enhancing breast reconstruction post mastectomy for breast cancer patients Sports medicine indications, including ACL repair Promotion of bone regeneration in foot and ankle surgery

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Lattice Biologics Ltd. 512 E Madison Ave. Suite 101 Belgrade, MT 59714
Telephone
Telephone
+1.406-570-2658
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20210709005421/en

BUSINESSWIRE
09 Jul 2021

https://www.businesswire.com/news/home/20210315005261/en/Lattice-Biologics-Reorganizes-to-Focus-on-Psychedelics-and-Cannabis-Therapies

BUSINESSWIRE
15 Mar 2021

https://www.businesswire.com/news/home/20200902005975/en/COVID19-UPDATE-%E2%80%93-Lattice-Biologics-Announces-Cessation

BUSINESSWIRE
03 Sep 2020

https://www.businesswire.com/news/home/20200608005775/en/Lattice-Biologics-Eliminates-CAN838000-Debt#:~:text=BELGRADE%2C%20Mont.%2D%2D(BUSINESS%20WIRE,Company%20to%20settle%20outstanding%20debt.

BUSINESSWIRE
08 Jun 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty